TABLE 2.
RAVLT learning slope and process scores for the diagnostic groups and total sample.
| Variable | CN | EOAD | EOnonAD | Total sample | Omnibus effect size (with 95% CI) |
|---|---|---|---|---|---|
| N | 82 | 166 | 62 | 310 | |
| RAVLT LRa,b,c | 0.75 (0.2; 0.38–1.00) | 0.27 (0.2; 0.00–1.00) | 0.46 (0.3; 0.08–1.00) | 0.44 (0.3; 0.00–1.00) | 1.94(1.67–2.21) |
| RAVLT RLSa,b,c | 7.10(1.9; 3.00–11.00) | 3.27 (1.8; 0.00–11.00) | 4.65 (2.5; 1.00–11.00) | 4.55 (2.6; 0.00–11.00) | 1.38(1.14–1.63) |
| RAVLT LOa,b,c | 20.88 (6.7; 8.00–37.00) | 8.26 (5.9; −4.00–33.00) | 11.97(7.8; −1.00–33.00) | 12.34 (8.4; −4.00–37.00) | 1.41(1.17–1.66) |
| RAVLT trial 1a,c | 5.51(1.7; 2.00–10.00) | 2.77 (1.7; 0.00–8.00) | 4.55(2.0; 1.00–11.00) | 3.85 (2.1; 0.00–11.00) | 1.29(1.04–1.53) |
Note: All values are mean (standard deviation; range) unless listed otherwise. Omnibus effect size is the effect size of omnibus multivariate analyses of covariances expressed as Cohen’s d.
Abbreviations: CI, compatibility interval; CN, cognitively normal; EOAD, early-onset Alzheimer’s disease; EOnonAD, early-onset non-Alzheimer’s disease; LR, learning ratio; RAVLT, Rey Auditory Verbal Learning Test; RLS, raw learning score; LOT, learning over trials.
a
Denotes significant difference between CN and EOAD groups.
b
Denotes significant difference between CN and EOnonAD groups.
c
Denotes significant difference between EOAD and EOnonAD groups.